NCT06257914

Brief Summary

Cataracts are a clouding of the lens of the eye. Cataract surgery replaces the cloudy lens with a clear artificial lens. It is one of the leading causes of low vision worldwide. Since cataracts are mostly age-related, the number of patients with cataracts is increasing sharply due to an ageing population. The indication for cataract surgery is currently based on the visual impairment experienced by the patient, a measurement of visual acuity and the ophthalmologist's assessment of the extent to which the clouding of the lens explains the patient's symptoms. It has been said that after cataract surgery, "the world opens up to you". However, about 10% of patients actually experience worse vision after surgery. This amounts to almost a whole month of potentially unnecessary surgery. It is therefore important to develop a more objective indicator for cataract surgery. Our study focuses on measuring the optical quality of the eye before and after cataract surgery. The investigators also ask patients before and after cataract surgery how patients themselves perceive the quality of their vision. The investigators do this with different patient-reported outcomes. The investigators investigate whether the objective measurement of the optical quality of the eye can predict which patients will be satisfied with the cataract surgery. With this, the investigators aim to further improve patient care and prevent unnecessary surgery.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

May 6, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

July 3, 2024

Status Verified

February 1, 2024

Enrollment Period

1.2 years

First QC Date

February 6, 2024

Last Update Submit

July 2, 2024

Conditions

Keywords

aberrometrystraylightPROMcataractindication for cataract surgery

Outcome Measures

Primary Outcomes (4)

  • log(VSX)

    preoperative aberrometry measurements, expressed as log(VSX)

    From enrollment to one year after cataract surgery

  • log(s)

    preoperative straylight measurements, expressed as log(s)

    From enrollment to one year after cataract surgery

  • preoperative Catquest-9SF score (expressed as Rasch score)

    preoperative Catquest-9SF score, expressed as Rasch score

    From enrollment to one year after cataract surgery

  • postoperative Catquest-9SF score (expressed as Rasch score)

    postoperative Catquest-9SF score, expressed as Rasch score

    From enrollment to one year after cataract surgery

Study Arms (1)

Cataract

Patients with cataract in both eyes

Diagnostic Test: Catquest-9SF

Interventions

Catquest-9SFDIAGNOSTIC_TEST

Measurement of self-assessed visual function with Catquest-9SF, measurement of ocular aberrations with iTrace (Tracey Technologies), and straylight measurements with C-Quant (Oculus)

Also known as: Aberrometry (iTrace), Straylight measurement (C-Quant)
Cataract

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Ophthalmic patients with cataracts in both eyes seeking surgery on them

You may qualify if:

  • At least 18 years old,
  • Diagnosis of cataract in both eyes,
  • Based on informed consent, will undergo cataract surgery in both eyes (not necessarily immediately bilateral),
  • Expected best-corrected visual acuity ≥ 0.7 in both eyes,
  • Pupil diameter in mydriasis ≥4 mm and
  • Implantation of a (standard) monofocal, toric monofocal or (non)toric Extended Depth of Focus artificial lens.

You may not qualify if:

  • Insufficient understanding of the Dutch language to comply with study procedures,
  • Spherical refraction of ≤-15 dioptres (due to impossibility of measurement with aberrometer),
  • Corneal astigmatism of ≥3 dioptres (because of possible effect on reliability of straylight measurement),
  • Implantation of a multifocal artificial lens (because the aberrometer \[still\] cannot properly determine the optical quality of this type of artificial lens),
  • Cataract surgery of the second eye not performed 3 months after surgery of the first eye,
  • Comorbidity (other than cataract) that may significantly affect vision or give prolonged duration of vision recovery, such as Fuchs\' endothelial cell dystrophy, significant macular degeneration, glaucoma, diabetic maculo- or retinopathy, or an experienced cerebral vascular accident,
  • A history of eye surgery (such as corneal refractive surgery and phakic lens implantation),
  • An increased risk of complicated cataract surgery, such as lens (sub)luxation, brunescent cataract, posterior polar cataract and a history of trauma to the eye,
  • Unable to be reliably measured with aberrometer or straylight meter, and
  • A peroperative or postoperative complication that significantly affects vision and has not recovered within 3 months of surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amphia

Breda, North Brabant, 4818 CK, Netherlands

Location

MeSH Terms

Conditions

Cataract

Interventions

Aberrometry

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, OphthalmologicalDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Nic J Reus, MD, PhD

    Amphia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2024

First Posted

February 14, 2024

Study Start

May 6, 2024

Primary Completion

August 1, 2025

Study Completion

November 1, 2025

Last Updated

July 3, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations